Editor's choice

A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy
Paul Emery, Jiří Vencovský, Anna Sylwestrzak, Piotr Leszczyński, Wieslawa Porawska, Asta Baranauskaite, Vira Tseluyko, Vyacheslav M Zhdan, Barbara Stasiuk, Roma Milasiene, Aaron Alejandro Barrera Rodriguez, Soo Yeon Cheong, Jeehoon Ghil

Annals of the Rheumatic Diseases Jan 2017, 76 (1) 51-57; DOI: 10.1136/annrheumdis-2015-207588
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
Munther Khamashta, Joan T Merrill, Victoria P Werth, Richard Furie, Kenneth Kalunian, Gabor G Illei, Jorn Drappa, Liangwei Wang, Warren Greth

Annals of the Rheumatic Diseases Nov 2016, 75 (11) 1909-1916; DOI: 10.1136/annrheumdis-2015-208562
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis
Rucsandra Dobrota, Britta Maurer, Nicole Graf, Suzana Jordan, Carina Mihai, Otylia Kowal-Bielecka, Yannick Allanore, Oliver Distler

Annals of the Rheumatic Diseases Oct 2016, 75 (10) 1743-1748; DOI: 10.1136/annrheumdis-2015-208024
Methotrexate dosage as a source of bias in biological trials in rheumatoid arthritis: a systematic review
Josefina Durán, Margarita Bockorny, Deepan Dalal, Michael LaValley, David T Felson

Annals of the Rheumatic Diseases Sep 2016, 75 (9) 1595-1598; DOI: 10.1136/annrheumdis-2016-209383
Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS)
Joachim Sieper, Joachim Listing, Denis Poddubnyy, In-Ho Song, Kay-Geert Hermann, Johanna Callhoff, Uta Syrbe, Jürgen Braun, Martin Rudwaleit

Annals of the Rheumatic Diseases Aug 2016, 75 (8) 1438-1443; DOI: 10.1136/annrheumdis-2015-207897
Platelets in rheumatoid arthritis: exploring the anti-inflammatory and antithrombotic potential of TNF inhibitors
Armen Yuri Gasparyan, George D Kitas

Annals of the Rheumatic Diseases Aug 2016, 75 (8) 1426-1427; DOI: 10.1136/annrheumdis-2015-208720
Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden
Hjalmar Wadström, Thomas Frisell, Pär Sparén, Johan Askling

Annals of the Rheumatic Diseases Jul 2016, 75 (7) 1272-1278; DOI: 10.1136/annrheumdis-2015-208263
Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose–response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)—a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial
Tsutomu Takeuchi, Yoshiya Tanaka, Naoki Ishiguro, Hisashi Yamanaka, Toshiyuki Yoneda, Takeshi Ohira, Naoki Okubo, Harry K Genant, Désirée van der Heijde

Annals of the Rheumatic Diseases Jun 2016, 75 (6) 983-990; DOI: 10.1136/annrheumdis-2015-208052
Preliminary definitions of ‘flare’ in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative
Laure Gossec, Agnès Portier, Robert Landewé, Adrien Etcheto, Victoria Navarro-Compán, Féline Kroon, Désirée van der Heijde, Maxime Dougados

Annals of the Rheumatic Diseases Jun 2016, 75 (6) 991-996; DOI: 10.1136/annrheumdis-2015-208593
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score
Monika M Schoels, Daniel Aletaha, Farideh Alasti, Josef S Smolen

Annals of the Rheumatic Diseases May 2016, 75 (5) 811-818; DOI: 10.1136/annrheumdis-2015-207507

Main menu

Editor's choice

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Editor's choice

Pages